Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Genes Section Short Communication FACC (Fanconi anaemia complementation group C) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France Published in Atlas Database: February 1998 Online version is available at: http://AtlasGeneticsOncology.org/Genes/FACC101.html DOI: 10.4267/2042/32097 This work is licensed under a Creative Commons Attribution-Non commercial-No Derivative Works 2.0 France Licence. © 1998 Atlas of Genetics and Cytogenetics in Oncology and Haematology Function Identity Peak expression during the G2/M transition; binds to cdc2 (mitotic cyclin-dependent kinase); probably involved in basic aspect(s) of the cell protection against DNA damages: role in the cell cycle regulation and/or in DNA repair and/or in the prevention of cellular apoptosis; binds to FAA, the protein encoded by FA1 (Fanconi anaemia complementation group A), the dimer being found in the cytoplasm and the nucleus. Other names: FAC Location: in 9q22.3 Local order: next to PTCH and XPAC. Homology No known homology. Mutations Probe(s) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics. Germinal DNA/RNA Mainly nucleotide substitutions, dispersed along the coding sequence. Description Implicated in 14 exons; spans 80 kb. Fanconi anaemia; FACC is implicated in the FA complementation group C Transcription mRNA of 2.3, 3.2, and 4.6 kb (variable 3' untranslated region, alternative splicing, exon skipping). Disease Fanconi anaemia is a chromosome instability syndrome/cancer prone disease (at risk of leukaemia). Protein Prognosis Poor; mean survival is 16 years: patients die of bone marrow failure (infections, haemorrhages), leukaemia, or androgen therapy related liver tumours. Description 558 amino acids; 63 kDa; alpha helical structure in Cterm. Cytogenetics Expression Spontaneous, chromatid/chromosome breaks; increased rate of breaks compared to control, when induced by breaking agent. Wide, in particular in the bones. Localisation References Cytoplasmic at any cell-cycle stage. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 1992;356:763-767. Atlas Genet Cytogenet Oncol Haematol. 1998; 2(1) 10 FACC (Fanconi anaemia complementation group C) Huret JL Gibson RA, Buchwald M, Roberts RG, Mathew CG. Characterisation of the exon structure of the Fanconi anaemia group C gene by vectorette PCR. Hum Mol Genet 1993;2:3538. Kupfer GM, Näf D, Suliman A, Pulsipher M, D'Andrea AD. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex. Nat Genet 1997 Dec;17(4):487-90. D'Andrea AD, Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood 1997;90(5):1725-36. This article should be referenced as such: Atlas Genet Cytogenet Oncol Haematol. 1998; 2(1) Huret JL. FACC (Fanconi anaemia complementation group C). Atlas Genet Cytogenet Oncol Haematol.1998;2(1):10-11. 11